BRCA2 Mutation as a Possible Cause of Poor Response to 177Lu-PSMA Therapy

Title
BRCA2 Mutation as a Possible Cause of Poor Response to 177Lu-PSMA Therapy
Authors
Keywords
-
Journal
CLINICAL NUCLEAR MEDICINE
Volume 43, Issue 8, Pages 609-610
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2018-05-16
DOI
10.1097/rlu.0000000000002141

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started